Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by themagicboxon Feb 24, 2020 11:42am

136 Views

Post# 30726210

RE:Who posts 94 times about a penny stock.

lol if you read the said "94" comments you'd find all my rationale....my predictions are coming true, never concealed anything....

DELAY is coming, with an accompanying dip. If delay in recruitment happens *wink* *wink* financing will likely follow....go read the 94 comments to understand why haha

mystic1689 wrote: My first thought was who and why would somebody post negatively only about ATE a penny stock and do it 94 times seems a little odd. But then I married it up with somebody who would call the testing facilities once again a teeny weeny penny stock and bingo we find odd. Oh and tease about the research but will conceal till the appropriate time. Oh my......sad.

Bullboard Posts

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide